TGFB1 and myocardial infarction: Moreover, TGFβ1 is a key pro-fibrotic cytokine that is markedly elevated in experimental MI, and anti-TGF gene therapy mitigates cardiac remodeling by affecting cardiac fibrosis and infarct tissue dynamics (Okada et al., 2005).